This website is made possible by third party financial support from Sage Therapeutics, Inc. and Biogen Inc.

This website is made possible by third party financial support from Sage Therapeutics, Inc. and Biogen Inc.

Videos

Jennifer Payne, MD, discusses her research into epigenetic biomarkers for postpartum depression, next steps for developing a test that accurately detects biomarkers, improving treatment outcomes by catching at-risk patients, and the possibility of one day preventing postpartum depression.
Michael Banov, MD, explains the mechanism of action for esketamine, the pros, and cons of use for treating major depressive disorder, and highlights questions that remain.